MedAdvisor Stock

MedAdvisor Stock-Based Compensation

Delisted

The Stock-Based Compensation (SBC) of MedAdvisor (MDR.AX) as of Aug 17, 2026 is 1.83 M AUD. In the previous year, Stock-Based Compensation (SBC) was 2.05 M AUD — a change of -10.70% (lower).

Stock-Based Compensation

1.83 MAUD

YoY

-10.70%

Last updated:

Stock-Based Compensation (SBC) of MedAdvisor is 2026 1.83 M AUD. Stock-Based Compensation (SBC) of MedAdvisor was 2025 2.05 M AUD. It decreases by -10.70% lower compared to the previous year.
Access this data via the Eulerpool API

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

Stock-Based Compensation (SBC) of MedAdvisor is 1.83 M AUD in 2026.

Stock-Based Compensation (SBC) of MedAdvisor changed from 2.05 M AUD to 1.83 M AUD, representing a -10.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s MedAdvisor historically and in real time.

Access this data via the Eulerpool API

Cash Flow — MedAdvisor

All Key Metrics — MedAdvisor